The rising prevalence in GLP-1 agonists for metabolic conditions has sparked a debate about delivery routes : patches versus capsules. Traditionally , GLP-1 therapies were only available in tablet form, but the introduction of patches presents a alternative choice . Transdermal systems might benefit individuals experiencing difficulty with table… Read More